BR-111A

N/A

Report date: 2025/03/04 10:46:16

Base Information

Drug NameBR-111A
Drug Alias NameBR-111ABR111ABR-111-A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1
Therapy Area/IndicationsSolid tumoursHematologic DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang BioRay Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang BioRay Biopharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A